| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 2.54e-04 | 739 | 46 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 3.38e-04 | 12 | 46 | 2 | GO:1990817 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.41e-04 | 303 | 46 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.06e-03 | 21 | 46 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZKSCAN8 FOXO3 NFKBIZ ZBTB2 USF3 HIVEP1 NFAT5 CLOCK CREBBP LHX9 | 1.51e-03 | 1459 | 46 | 10 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription factor binding | 1.57e-03 | 753 | 46 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.74e-03 | 562 | 46 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | poly(A) binding | 2.03e-03 | 29 | 46 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 2.31e-03 | 31 | 46 | 2 | GO:0070566 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 7.72e-07 | 33 | 45 | 4 | GO:0000289 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.33e-06 | 16 | 45 | 3 | GO:0060211 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXO3 NFKBIZ KMT2C USF3 POGZ MAML2 HIVEP1 NFAT5 CLOCK CREBBP ASXL3 MED13 BRD4 | 5.33e-06 | 1390 | 45 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.21e-05 | 65 | 45 | 4 | GO:0000288 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.74e-05 | 27 | 45 | 3 | GO:1900151 | |
| GeneOntologyBiologicalProcess | RNA 3'-end processing | 6.15e-05 | 98 | 45 | 4 | GO:0031123 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 1.38e-04 | 46 | 45 | 3 | GO:0031124 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.89e-04 | 389 | 45 | 6 | GO:0022409 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 1.95e-04 | 132 | 45 | 4 | GO:0000956 | |
| GeneOntologyBiologicalProcess | cell cycle process | PKN2 POGZ LATS1 FBXO6 TDRD9 TENT4A CLOCK CREBBP CHMP1B BRD4 PKP4 | 2.07e-04 | 1441 | 45 | 11 | GO:0022402 |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.03e-04 | 12 | 45 | 2 | GO:1900152 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 4.17e-04 | 14 | 45 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | regulation of mRNA 3'-end processing | 4.17e-04 | 14 | 45 | 2 | GO:0031440 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell differentiation | 4.17e-04 | 14 | 45 | 2 | GO:2000321 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FOXO3 KMT2C PHC3 DDX20 SCML2 TENT4A CLOCK PABPC1 CREBBP CHMP1B ASXL3 MED13 PABPC3 BRD4 | 8.82e-07 | 1377 | 46 | 14 | GO:0140513 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.88e-06 | 269 | 46 | 7 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.89e-06 | 287 | 46 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | mCRD-mediated mRNA stability complex | 7.07e-05 | 6 | 46 | 2 | GO:0106002 | |
| GeneOntologyCellularComponent | nuclear body | NFKBIZ SRSF11 PKN2 DDX20 ATP6V0A1 MAML2 HIVEP1 CREBBP NUFIP2 | 1.31e-04 | 903 | 46 | 9 | GO:0016604 |
| GeneOntologyCellularComponent | PcG protein complex | 2.04e-04 | 52 | 46 | 3 | GO:0031519 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription repressor complex | 6.31e-04 | 17 | 46 | 2 | GO:0090571 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 7.09e-04 | 18 | 46 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | cell leading edge | 7.56e-04 | 500 | 46 | 6 | GO:0031252 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 1.23e-03 | 96 | 46 | 3 | GO:0010494 | |
| GeneOntologyCellularComponent | midbody | 1.42e-03 | 222 | 46 | 4 | GO:0030496 | |
| GeneOntologyCellularComponent | lamellipodium | 1.62e-03 | 230 | 46 | 4 | GO:0030027 | |
| HumanPheno | Self-injurious behavior | 1.67e-05 | 210 | 15 | 6 | HP:0100716 | |
| HumanPheno | Autistic behavior | 2.95e-05 | 678 | 15 | 9 | HP:0000729 | |
| HumanPheno | Diagnostic behavioral phenotype | 6.52e-05 | 747 | 15 | 9 | HP:0025783 | |
| HumanPheno | Disinhibition | 1.22e-04 | 807 | 15 | 9 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 1.22e-04 | 807 | 15 | 9 | HP:0000719 | |
| HumanPheno | Abnormal response to social norms | 1.22e-04 | 807 | 15 | 9 | HP:5200123 | |
| HumanPheno | Social disinhibition | 1.22e-04 | 807 | 15 | 9 | HP:5200029 | |
| HumanPheno | Reduced impulse control | IRAK1 KMT2C POGZ ATP6V0A1 CREBBP PODXL ASXL3 MED13 BRD4 GABBR1 | 1.24e-04 | 1032 | 15 | 10 | HP:5200045 |
| HumanPheno | Abnormally increased volition | 2.21e-04 | 869 | 15 | 9 | HP:5200263 | |
| HumanPheno | Impairment in personality functioning | IRAK1 KMT2C POGZ ATP6V0A1 CREBBP PODXL ASXL3 MED13 BRD4 GABBR1 | 3.01e-04 | 1141 | 15 | 10 | HP:0031466 |
| HumanPheno | Abnormal social development | 3.13e-04 | 908 | 15 | 9 | HP:0025732 | |
| HumanPheno | Aggressive behavior | 3.27e-04 | 516 | 15 | 7 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 3.27e-04 | 516 | 15 | 7 | HP:0006919 | |
| MousePheno | abnormal estrous cycle | 6.60e-07 | 120 | 37 | 6 | MP:0001927 | |
| MousePheno | abnormal ovulation cycle | 8.80e-07 | 126 | 37 | 6 | MP:0009344 | |
| MousePheno | short premaxilla | 4.79e-06 | 13 | 37 | 3 | MP:0000091 | |
| MousePheno | abnormal circulating pituitary hormone level | 5.39e-06 | 172 | 37 | 6 | MP:0005116 | |
| MousePheno | prolonged estrus | 9.34e-06 | 16 | 37 | 3 | MP:0009017 | |
| MousePheno | abnormal circulating gonadotropin level | 1.07e-05 | 112 | 37 | 5 | MP:0003361 | |
| MousePheno | abnormal pituitary hormone level | 1.88e-05 | 214 | 37 | 6 | MP:0003965 | |
| MousePheno | abnormal luteinizing hormone level | 2.36e-05 | 64 | 37 | 4 | MP:0003969 | |
| MousePheno | small premaxilla | 3.77e-05 | 25 | 37 | 3 | MP:0004870 | |
| MousePheno | abnormal estrus | 9.65e-05 | 34 | 37 | 3 | MP:0009016 | |
| MousePheno | abnormal premaxilla morphology | 1.46e-04 | 39 | 37 | 3 | MP:0002820 | |
| MousePheno | abnormal CNS synaptic transmission | FOXO3 SRSF11 POGZ ATP6V0A1 HIVEP1 LATS1 CREBBP BRD4 GABBR1 NUFIP2 | 1.74e-04 | 985 | 37 | 10 | MP:0002206 |
| MousePheno | short proestrus | 1.89e-04 | 8 | 37 | 2 | MP:0009015 | |
| MousePheno | absent estrous cycle | 2.10e-04 | 44 | 37 | 3 | MP:0009009 | |
| MousePheno | abnormal synaptic transmission | FOXO3 SRSF11 POGZ ATP6V0A1 HIVEP1 LATS1 CREBBP BRD4 GABBR1 NUFIP2 | 3.41e-04 | 1070 | 37 | 10 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | FOXO3 SRSF11 POGZ ATP6V0A1 HIVEP1 LATS1 CREBBP BRD4 GABBR1 NUFIP2 | 3.57e-04 | 1076 | 37 | 10 | MP:0021009 |
| MousePheno | decreased hematopoietic stem cell number | 4.53e-04 | 57 | 37 | 3 | MP:0004810 | |
| MousePheno | abnormal prepulse inhibition | 4.74e-04 | 542 | 37 | 7 | MP:0003088 | |
| MousePheno | abnormal proestrus | 5.22e-04 | 13 | 37 | 2 | MP:0009013 | |
| MousePheno | increased circulating gonadotropin level | 6.36e-04 | 64 | 37 | 3 | MP:0003362 | |
| Domain | PolyA | 5.91e-05 | 5 | 46 | 2 | SM00517 | |
| Domain | - | 5.91e-05 | 5 | 46 | 2 | 1.10.1900.10 | |
| Domain | PABP | 5.91e-05 | 5 | 46 | 2 | PF00658 | |
| Domain | PABC | 5.91e-05 | 5 | 46 | 2 | PS51309 | |
| Domain | PABP_1234 | 5.91e-05 | 5 | 46 | 2 | IPR006515 | |
| Domain | PABP_HYD | 5.91e-05 | 5 | 46 | 2 | IPR002004 | |
| Domain | NTP_transf_2 | 3.22e-04 | 11 | 46 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 3.22e-04 | 11 | 46 | 2 | IPR002934 | |
| Domain | SAM_1 | 6.26e-04 | 68 | 46 | 3 | PF00536 | |
| Domain | SAM | 1.33e-03 | 88 | 46 | 3 | SM00454 | |
| Domain | RRM_dom_euk | 1.45e-03 | 23 | 46 | 2 | IPR003954 | |
| Domain | RRM_1 | 1.45e-03 | 23 | 46 | 2 | SM00361 | |
| Domain | SAM_DOMAIN | 1.65e-03 | 95 | 46 | 3 | PS50105 | |
| Domain | SAM | 1.75e-03 | 97 | 46 | 3 | IPR001660 | |
| Domain | Bromodomain_CS | 1.86e-03 | 26 | 46 | 2 | IPR018359 | |
| Domain | - | 2.26e-03 | 106 | 46 | 3 | 1.10.150.50 | |
| Domain | SAM/pointed | 2.99e-03 | 117 | 46 | 3 | IPR013761 | |
| Domain | BROMODOMAIN_1 | 3.74e-03 | 37 | 46 | 2 | PS00633 | |
| Domain | Pkinase_C | 3.74e-03 | 37 | 46 | 2 | IPR017892 | |
| Domain | Bromodomain | 3.94e-03 | 38 | 46 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.58e-03 | 41 | 46 | 2 | PS50014 | |
| Domain | Pkinase_C | 4.80e-03 | 42 | 46 | 2 | PF00433 | |
| Domain | BROMO | 4.80e-03 | 42 | 46 | 2 | SM00297 | |
| Domain | Bromodomain | 4.80e-03 | 42 | 46 | 2 | IPR001487 | |
| Domain | - | 4.80e-03 | 42 | 46 | 2 | 1.20.920.10 | |
| Domain | AGC-kinase_C | 8.40e-03 | 56 | 46 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 8.40e-03 | 56 | 46 | 2 | PS51285 | |
| Domain | S_TK_X | 8.40e-03 | 56 | 46 | 2 | SM00133 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 4.50e-05 | 26 | 38 | 3 | M47923 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PHC3 PKN2 DDX20 SCML2 POGZ HIVEP1 LATS1 PAPOLA PRG4 MED13 BRD4 SAMD4B | 2.64e-10 | 774 | 46 | 12 | 15302935 |
| Pubmed | 3.74e-08 | 549 | 46 | 9 | 38280479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.89e-08 | 398 | 46 | 8 | 35016035 | |
| Pubmed | 3.25e-07 | 709 | 46 | 9 | 22988430 | ||
| Pubmed | 9.62e-07 | 808 | 46 | 9 | 20412781 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.62e-06 | 861 | 46 | 9 | 36931259 | |
| Pubmed | CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. | 1.71e-06 | 2 | 46 | 2 | 31504797 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19020299 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26971890 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11704675 | ||
| Pubmed | Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis. | 1.71e-06 | 2 | 46 | 2 | 10954604 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 10534404 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 34549306 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 9732454 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15831480 | ||
| Pubmed | Nucleotide sequence of a mouse testis poly(A) binding protein cDNA. | 1.71e-06 | 2 | 46 | 2 | 1630930 | |
| Pubmed | Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse. | 1.71e-06 | 2 | 46 | 2 | 7893484 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.39e-06 | 462 | 46 | 7 | 31138677 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.75e-06 | 954 | 46 | 9 | 36373674 | |
| Pubmed | PXN SRSF11 LATS1 PAPOLA NFAT5 PABPC1 MED13 PKP4 FAM83B NUFIP2 | 4.26e-06 | 1247 | 46 | 10 | 27684187 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 26134869 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 11328870 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 25034140 | ||
| Pubmed | Epab is dispensable for mouse spermatogenesis and male fertility. | 5.13e-06 | 3 | 46 | 2 | 24599567 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 34101965 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 29578408 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 22474372 | ||
| Pubmed | SIRT1 Functions as a Negative Regulator of Eukaryotic Poly(A)RNA Transport. | 5.13e-06 | 3 | 46 | 2 | 28756945 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 26843391 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 29701755 | ||
| Pubmed | Insulin-FOXO3 signaling modulates circadian rhythms via regulation of clock transcription. | 5.13e-06 | 3 | 46 | 2 | 24856209 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 21940797 | ||
| Pubmed | Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer. | 5.13e-06 | 3 | 46 | 2 | 30518851 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 28635594 | ||
| Pubmed | The mouse Y-box protein, MSY2, is associated with a kinase on non-polysomal mouse testicular mRNAs. | 5.13e-06 | 3 | 46 | 2 | 10076007 | |
| Pubmed | Epab and Pabpc1 are differentially expressed in the postnatal mouse ovaries. | 5.13e-06 | 3 | 46 | 2 | 25370180 | |
| Pubmed | Epab and Pabpc1 are differentially expressed during male germ cell development. | 5.13e-06 | 3 | 46 | 2 | 22814100 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 28611064 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 37665675 | ||
| Pubmed | De novo variants in the PABP domain of PABPC1 lead to developmental delay. | 5.13e-06 | 3 | 46 | 2 | 35511136 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 16804161 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 28252024 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 26164627 | ||
| Pubmed | CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. | 1.03e-05 | 4 | 46 | 2 | 19922678 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 28398509 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 15630085 | ||
| Pubmed | Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. | 1.03e-05 | 4 | 46 | 2 | 16606840 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 22059479 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 18490513 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 15314026 | ||
| Pubmed | Stress granules inhibit apoptosis by reducing reactive oxygen species production. | 1.03e-05 | 4 | 46 | 2 | 23230274 | |
| Pubmed | Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy. | 1.03e-05 | 4 | 46 | 2 | 31847264 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 9883581 | ||
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 1.03e-05 | 4 | 46 | 2 | 34536441 | |
| Pubmed | Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. | 1.03e-05 | 4 | 46 | 2 | 24129315 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 28910620 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 29444976 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 22956915 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 19328788 | ||
| Pubmed | Expression of genes involved in mammalian meiosis during the transition from egg to embryo. | 1.15e-05 | 33 | 46 | 3 | 11389549 | |
| Pubmed | FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). | 1.71e-05 | 5 | 46 | 2 | 15126506 | |
| Pubmed | Cryptochrome 1 regulates the circadian clock through dynamic interactions with the BMAL1 C terminus. | 1.71e-05 | 5 | 46 | 2 | 25961797 | |
| Pubmed | HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. | 1.71e-05 | 5 | 46 | 2 | 19956697 | |
| Pubmed | Interaction of HuDA and PABP at 5'UTR of mouse insulin2 regulates insulin biosynthesis. | 1.71e-05 | 5 | 46 | 2 | 29590218 | |
| Pubmed | Poly(A) tail length regulates PABPC1 expression to tune translation in the heart. | 1.71e-05 | 5 | 46 | 2 | 28653618 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 26492470 | ||
| Pubmed | Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway. | 1.71e-05 | 5 | 46 | 2 | 35349706 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 12192052 | ||
| Pubmed | Isolation of cDNAs from a mouse astroglial cell line by a subtracted cDNA library. | 1.71e-05 | 5 | 46 | 2 | 1701491 | |
| Pubmed | AKAP3 synthesis is mediated by RNA binding proteins and PKA signaling during mouse spermiogenesis. | 1.71e-05 | 5 | 46 | 2 | 24648398 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 33744966 | ||
| Pubmed | 1.81e-05 | 418 | 46 | 6 | 34709266 | ||
| Pubmed | 2.09e-05 | 1497 | 46 | 10 | 31527615 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 2.30e-05 | 910 | 46 | 8 | 36736316 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 16678094 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 17927953 | ||
| Pubmed | Translation of insulin granule proteins are regulated by PDI and PABP. | 2.56e-05 | 6 | 46 | 2 | 32248978 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 33945069 | ||
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 2.56e-05 | 6 | 46 | 2 | 20930143 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 10358005 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 30302808 | ||
| Pubmed | Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. | 2.56e-05 | 6 | 46 | 2 | 15961999 | |
| Pubmed | 2.61e-05 | 446 | 46 | 6 | 24255178 | ||
| Pubmed | 2.77e-05 | 268 | 46 | 5 | 33640491 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | 2.99e-05 | 457 | 46 | 6 | 32968282 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 34143182 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 25515214 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 11322760 | ||
| Pubmed | Chromosomal localization of three human poly(A)-binding protein genes and four related pseudogenes. | 3.58e-05 | 7 | 46 | 2 | 10543404 | |
| Pubmed | NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome. | 3.58e-05 | 7 | 46 | 2 | 34784943 | |
| Pubmed | 4.21e-05 | 486 | 46 | 6 | 20936779 | ||
| Pubmed | 4.24e-05 | 146 | 46 | 4 | 21589869 | ||
| Pubmed | 4.57e-05 | 52 | 46 | 3 | 26265008 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 4.66e-05 | 495 | 46 | 6 | 27705803 | |
| Pubmed | Over-expression of Grhl2 causes spina bifida in the Axial defects mutant mouse. | 4.77e-05 | 8 | 46 | 2 | 21262862 | |
| Pubmed | An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. | 4.77e-05 | 8 | 46 | 2 | 15890782 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 22621333 | ||
| Pubmed | 6.03e-05 | 57 | 46 | 3 | 18022353 | ||
| Pubmed | Oxidative stress-dependent regulation of Forkhead box O4 activity by nemo-like kinase. | 6.12e-05 | 9 | 46 | 2 | 20874444 | |
| Pubmed | RNA binding protein RBM46 regulates mitotic-to-meiotic transition in spermatogenesis. | 6.12e-05 | 9 | 46 | 2 | 36001654 | |
| Interaction | OGT interactions | ZKSCAN8 KMT2C PHC3 SRSF11 HIVEP1 LATS1 PABPC1 CREBBP ASXL3 BRD4 PKP4 NUFIP2 | 9.90e-07 | 950 | 46 | 12 | int:OGT |
| Interaction | PAPOLA interactions | 2.10e-06 | 92 | 46 | 5 | int:PAPOLA | |
| Interaction | WWTR1 interactions | 4.50e-06 | 422 | 46 | 8 | int:WWTR1 | |
| Interaction | CREBBP interactions | 7.03e-06 | 599 | 46 | 9 | int:CREBBP | |
| Interaction | YAP1 interactions | KMT2C SCML2 POGZ LATS1 PAPOLA NFAT5 PABPC1 CREBBP PABPC3 BRD4 NUFIP2 | 2.67e-05 | 1095 | 46 | 11 | int:YAP1 |
| Interaction | ZNF592 interactions | 3.48e-05 | 81 | 46 | 4 | int:ZNF592 | |
| Interaction | PUM1 interactions | 4.59e-05 | 287 | 46 | 6 | int:PUM1 | |
| Interaction | GSC interactions | 4.60e-05 | 87 | 46 | 4 | int:GSC | |
| Interaction | EEF1A1 interactions | 4.72e-05 | 762 | 46 | 9 | int:EEF1A1 | |
| Interaction | N4BP2 interactions | 5.03e-05 | 89 | 46 | 4 | int:N4BP2 | |
| Interaction | WDR48 interactions | 5.06e-05 | 177 | 46 | 5 | int:WDR48 | |
| Interaction | SOX9 interactions | 7.05e-05 | 97 | 46 | 4 | int:SOX9 | |
| Interaction | YTHDF2 interactions | 7.30e-05 | 312 | 46 | 6 | int:YTHDF2 | |
| Interaction | SNRNP200 interactions | 7.64e-05 | 460 | 46 | 7 | int:SNRNP200 | |
| Interaction | SMG7 interactions | 8.25e-05 | 319 | 46 | 6 | int:SMG7 | |
| Interaction | YWHAG interactions | FOXO3 SRSF11 PKN2 HIVEP1 LATS1 FBXO6 PABPC1 RASSF2 SAMD4B FAM83B NUFIP2 | 8.78e-05 | 1248 | 46 | 11 | int:YWHAG |
| Interaction | LHX1 interactions | 8.90e-05 | 103 | 46 | 4 | int:LHX1 | |
| Interaction | CEP131 interactions | 9.02e-05 | 200 | 46 | 5 | int:CEP131 | |
| Interaction | DCP1B interactions | 9.24e-05 | 104 | 46 | 4 | int:DCP1B | |
| Interaction | FEV interactions | 9.67e-05 | 203 | 46 | 5 | int:FEV | |
| Interaction | NANOG interactions | 1.01e-04 | 481 | 46 | 7 | int:NANOG | |
| Interaction | CBX4 interactions | 1.01e-04 | 205 | 46 | 5 | int:CBX4 | |
| Interaction | CLTC interactions | 1.04e-04 | 655 | 46 | 8 | int:CLTC | |
| Interaction | LGALS3 interactions | 1.17e-04 | 340 | 46 | 6 | int:LGALS3 | |
| Interaction | TBR1 interactions | 1.28e-04 | 113 | 46 | 4 | int:TBR1 | |
| Interaction | POLR1E interactions | 1.37e-04 | 350 | 46 | 6 | int:POLR1E | |
| Interaction | TBXT interactions | 1.41e-04 | 116 | 46 | 4 | int:TBXT | |
| Interaction | DDB1 interactions | 1.60e-04 | 697 | 46 | 8 | int:DDB1 | |
| Interaction | PABPC1 interactions | 1.63e-04 | 699 | 46 | 8 | int:PABPC1 | |
| Interaction | TDRD9 interactions | 1.82e-04 | 9 | 46 | 2 | int:TDRD9 | |
| Interaction | DNAJA1 interactions | 1.90e-04 | 533 | 46 | 7 | int:DNAJA1 | |
| Interaction | CMAS interactions | 2.00e-04 | 127 | 46 | 4 | int:CMAS | |
| Interaction | TERF2IP interactions | 2.36e-04 | 552 | 46 | 7 | int:TERF2IP | |
| Interaction | MOB1B interactions | 2.54e-04 | 54 | 46 | 3 | int:MOB1B | |
| Interaction | SCMH1 interactions | 2.54e-04 | 54 | 46 | 3 | int:SCMH1 | |
| Interaction | IRF5 interactions | 2.54e-04 | 54 | 46 | 3 | int:IRF5 | |
| Interaction | PNKP interactions | 2.67e-04 | 137 | 46 | 4 | int:PNKP | |
| Interaction | CREB1 interactions | 2.75e-04 | 254 | 46 | 5 | int:CREB1 | |
| Interaction | SRF interactions | 2.82e-04 | 139 | 46 | 4 | int:SRF | |
| Interaction | CSTF3 interactions | 2.82e-04 | 139 | 46 | 4 | int:CSTF3 | |
| Interaction | HELZ interactions | 2.90e-04 | 257 | 46 | 5 | int:HELZ | |
| Interaction | AURKB interactions | 2.91e-04 | 761 | 46 | 8 | int:AURKB | |
| Interaction | RUVBL1 interactions | 3.02e-04 | 575 | 46 | 7 | int:RUVBL1 | |
| Interaction | NFIB interactions | 3.06e-04 | 142 | 46 | 4 | int:NFIB | |
| Interaction | SLC25A3 interactions | 3.26e-04 | 411 | 46 | 6 | int:SLC25A3 | |
| Interaction | KIF11 interactions | 3.46e-04 | 267 | 46 | 5 | int:KIF11 | |
| Interaction | GMEB2 interactions | 3.48e-04 | 60 | 46 | 3 | int:GMEB2 | |
| Interaction | SMC5 interactions | 3.69e-04 | 1000 | 46 | 9 | int:SMC5 | |
| Interaction | TOP3B interactions | FOXO3 PXN IRAK1 KMT2C DDX20 HEG1 PABPC1 MED13 BRD4 SAMD4B NUFIP2 | 3.70e-04 | 1470 | 46 | 11 | int:TOP3B |
| Interaction | SEC16A interactions | 3.94e-04 | 426 | 46 | 6 | int:SEC16A | |
| Interaction | H4C16 interactions | 3.97e-04 | 152 | 46 | 4 | int:H4C16 | |
| Interaction | TNRC6A interactions | 4.30e-04 | 280 | 46 | 5 | int:TNRC6A | |
| Interaction | PAN3 interactions | 4.40e-04 | 65 | 46 | 3 | int:PAN3 | |
| Interaction | CBX6 interactions | 4.51e-04 | 283 | 46 | 5 | int:CBX6 | |
| Interaction | SNU13 interactions | 4.66e-04 | 285 | 46 | 5 | int:SNU13 | |
| Interaction | SUMO1 interactions | 4.81e-04 | 287 | 46 | 5 | int:SUMO1 | |
| Interaction | PLEKHG1 interactions | 4.81e-04 | 67 | 46 | 3 | int:PLEKHG1 | |
| Interaction | KLF4 interactions | 4.82e-04 | 160 | 46 | 4 | int:KLF4 | |
| Interaction | APEX1 interactions | ZKSCAN8 SCML2 POGZ ATP6V0A1 HIVEP1 LATS1 PAPOLA PABPC1 BRD4 PKP4 | 4.86e-04 | 1271 | 46 | 10 | int:APEX1 |
| Interaction | GCM1 interactions | 5.03e-04 | 68 | 46 | 3 | int:GCM1 | |
| Interaction | STAT3 interactions | 5.03e-04 | 446 | 46 | 6 | int:STAT3 | |
| Interaction | KDM6A interactions | 5.05e-04 | 162 | 46 | 4 | int:KDM6A | |
| Interaction | H3-4 interactions | 5.15e-04 | 448 | 46 | 6 | int:H3-4 | |
| Interaction | YY1 interactions | 5.52e-04 | 454 | 46 | 6 | int:YY1 | |
| Interaction | LHX4 interactions | 5.53e-04 | 166 | 46 | 4 | int:LHX4 | |
| Interaction | DCP1A interactions | 5.53e-04 | 166 | 46 | 4 | int:DCP1A | |
| Interaction | ATG12 interactions | 5.53e-04 | 296 | 46 | 5 | int:ATG12 | |
| Interaction | MOB1A interactions | 5.94e-04 | 72 | 46 | 3 | int:MOB1A | |
| Interaction | EGR2 interactions | 6.19e-04 | 171 | 46 | 4 | int:EGR2 | |
| Interaction | YWHAZ interactions | FOXO3 HIVEP1 LATS1 FBXO6 RASSF2 ASXL3 BRD4 GABBR1 SAMD4B FAM83B | 6.49e-04 | 1319 | 46 | 10 | int:YWHAZ |
| Interaction | LGALS8 interactions | 6.60e-04 | 174 | 46 | 4 | int:LGALS8 | |
| Interaction | JUN interactions | 6.62e-04 | 470 | 46 | 6 | int:JUN | |
| Interaction | RTF2 interactions | 6.70e-04 | 75 | 46 | 3 | int:RTF2 | |
| Interaction | TLX1 interactions | 6.75e-04 | 175 | 46 | 4 | int:TLX1 | |
| Interaction | MAML2 interactions | 6.78e-04 | 17 | 46 | 2 | int:MAML2 | |
| Interaction | CRABP2 interactions | 7.51e-04 | 78 | 46 | 3 | int:CRABP2 | |
| Interaction | HNF1A interactions | 8.09e-04 | 80 | 46 | 3 | int:HNF1A | |
| Interaction | PABPC3 interactions | 8.09e-04 | 80 | 46 | 3 | int:PABPC3 | |
| Interaction | TBKBP1 interactions | 8.09e-04 | 80 | 46 | 3 | int:TBKBP1 | |
| Interaction | CHAF1A interactions | 8.09e-04 | 322 | 46 | 5 | int:CHAF1A | |
| Interaction | LHX3 interactions | 8.30e-04 | 185 | 46 | 4 | int:LHX3 | |
| Interaction | SYCP3 interactions | 8.50e-04 | 19 | 46 | 2 | int:SYCP3 | |
| Interaction | GAPDH interactions | 8.65e-04 | 686 | 46 | 7 | int:GAPDH | |
| Interaction | H3C3 interactions | 8.67e-04 | 495 | 46 | 6 | int:H3C3 | |
| Interaction | BACE2 interactions | 8.69e-04 | 82 | 46 | 3 | int:BACE2 | |
| Interaction | GAK interactions | 8.99e-04 | 189 | 46 | 4 | int:GAK | |
| Interaction | TRA2A interactions | 9.03e-04 | 330 | 46 | 5 | int:TRA2A | |
| Interaction | HNF1B interactions | 9.17e-04 | 190 | 46 | 4 | int:HNF1B | |
| Cytoband | 6q25.1 | 6.75e-04 | 38 | 46 | 2 | 6q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 2.60e-03 | 75 | 46 | 2 | chr1q31 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.59e-04 | 17 | 34 | 2 | 486 | |
| GeneFamily | Sterile alpha motif domain containing | 5.98e-04 | 88 | 34 | 3 | 760 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 4.74e-08 | 195 | 46 | 7 | M4201 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 1.15e-06 | 195 | 46 | 6 | M4195 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 1.33e-06 | 200 | 46 | 6 | M7776 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.36e-06 | 466 | 46 | 8 | M13522 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 9.43e-06 | 807 | 46 | 9 | M16651 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.51e-05 | 856 | 46 | 9 | M4500 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.99e-05 | 189 | 46 | 5 | M3112 | |
| Coexpression | GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP | 2.15e-05 | 192 | 46 | 5 | M4174 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 2.55e-05 | 199 | 46 | 5 | M9236 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KMT2C PHC3 HEG1 LATS1 PAPOLA NFAT5 RASSF2 CREBBP FCRL6 MED13 NUFIP2 | 4.12e-05 | 1492 | 46 | 11 | M40023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 4.98e-05 | 115 | 46 | 4 | M7484 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | 9.86e-05 | 844 | 46 | 8 | M41129 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_ONLY | 1.34e-04 | 10 | 46 | 2 | MM1122 | |
| Coexpression | CSR_EARLY_UP.V1_UP | 1.51e-04 | 153 | 46 | 4 | M2656 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.70e-04 | 680 | 46 | 7 | M41089 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.77e-04 | 300 | 46 | 5 | M8702 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN | 2.74e-04 | 179 | 46 | 4 | M4259 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.80e-04 | 180 | 46 | 4 | M8239 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 3.37e-04 | 189 | 46 | 4 | M8275 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP | 3.37e-04 | 189 | 46 | 4 | M4199 | |
| Coexpression | GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP | 3.65e-04 | 193 | 46 | 4 | M4177 | |
| Coexpression | GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN | 3.65e-04 | 193 | 46 | 4 | M6138 | |
| Coexpression | GSE12366_NAIVE_VS_MEMORY_BCELL_UP | 3.80e-04 | 195 | 46 | 4 | M3178 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 3.87e-04 | 196 | 46 | 4 | M4244 | |
| Coexpression | GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP | 3.95e-04 | 197 | 46 | 4 | M4167 | |
| Coexpression | GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 4.02e-04 | 198 | 46 | 4 | M5346 | |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | 4.02e-04 | 198 | 46 | 4 | M3104 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 4.10e-04 | 199 | 46 | 4 | M3186 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 4.10e-04 | 199 | 46 | 4 | M3177 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 4.18e-04 | 200 | 46 | 4 | M9472 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 4.18e-04 | 200 | 46 | 4 | M9453 | |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_UP | 4.18e-04 | 200 | 46 | 4 | M3385 | |
| Coexpression | GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP | 4.18e-04 | 200 | 46 | 4 | M2933 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 4.18e-04 | 200 | 46 | 4 | M6552 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 4.52e-04 | 568 | 46 | 6 | MM3824 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 5.07e-06 | 778 | 46 | 10 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 6.13e-06 | 795 | 46 | 10 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.54e-06 | 330 | 46 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 6.55e-06 | 801 | 46 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 1.84e-05 | 387 | 46 | 7 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 1.84e-05 | 387 | 46 | 7 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 2.62e-05 | 409 | 46 | 7 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 3.42e-05 | 770 | 46 | 9 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.06e-05 | 178 | 46 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 4.78e-05 | 804 | 46 | 9 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.64e-04 | 127 | 46 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.31e-04 | 406 | 46 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.53e-04 | 413 | 46 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 2.64e-04 | 790 | 46 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.12e-04 | 275 | 46 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.18e-04 | 151 | 46 | 4 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.15e-04 | 162 | 46 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 4.25e-04 | 163 | 46 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 4.45e-04 | 165 | 46 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_100 | 5.11e-04 | 72 | 46 | 3 | gudmap_developingGonad_e18.5_ovary_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.32e-04 | 173 | 46 | 4 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.54e-04 | 74 | 46 | 3 | gudmap_developingGonad_e14.5_ testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_100 | 5.54e-04 | 74 | 46 | 3 | gudmap_developingGonad_e16.5_ovary_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 5.76e-04 | 75 | 46 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 6.98e-04 | 186 | 46 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.07e-04 | 339 | 46 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.37e-06 | 186 | 46 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 188 | 46 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-06 | 200 | 46 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.58e-05 | 166 | 46 | 4 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.65e-05 | 167 | 46 | 4 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 173 | 46 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 173 | 46 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 173 | 46 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 175 | 46 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 176 | 46 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.78e-05 | 183 | 46 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.20e-05 | 188 | 46 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 192 | 46 | 4 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.56e-05 | 192 | 46 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.65e-05 | 193 | 46 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.65e-05 | 193 | 46 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 356C|World / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 195 | 46 | 4 | b19609f519188cf27859cbdc014e65fc38e24391 | |
| ToppCell | COVID-19_Severe-CD4+_T_naive|COVID-19_Severe / Disease condition and Cell class | 5.04e-05 | 197 | 46 | 4 | ac26672bd2cb3bc9a11206d8da203bafec3931f6 | |
| ToppCell | Bronchial_Biopsy-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.24e-05 | 199 | 46 | 4 | be916332291ea48e244c05ab1855f9fcd718ac54 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 46 | 4 | fa99901388eec28004bef85d84f0d7d5bd4df4a8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 46 | 4 | 89eae23195d57f1b23a337ff19c9b8a367e22c96 | |
| Disease | Carcinoma, Transitional Cell | 3.63e-05 | 41 | 46 | 3 | C0007138 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.99e-04 | 206 | 46 | 4 | C0152013 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 3.58e-04 | 18 | 46 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | red blood cell density measurement | 3.98e-04 | 880 | 46 | 7 | EFO_0007978 | |
| Disease | Neurodevelopmental Disorders | 4.17e-04 | 93 | 46 | 3 | C1535926 | |
| Disease | Adenoid Cystic Carcinoma | 5.16e-04 | 100 | 46 | 3 | C0010606 | |
| Disease | Sezary Syndrome | 8.14e-04 | 27 | 46 | 2 | C0036920 | |
| Disease | Hyperplasia | 8.76e-04 | 28 | 46 | 2 | C0020507 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 8.76e-04 | 28 | 46 | 2 | EFO_0600005 | |
| Disease | Bladder Neoplasm | 1.37e-03 | 140 | 46 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.39e-03 | 141 | 46 | 3 | C0005684 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.73e-03 | 152 | 46 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Non-Small Cell Lung Carcinoma | 1.86e-03 | 156 | 46 | 3 | C0007131 | |
| Disease | autism spectrum disorder | 1.86e-03 | 156 | 46 | 3 | EFO_0003756 | |
| Disease | hip circumference | 1.89e-03 | 338 | 46 | 4 | EFO_0005093 | |
| Disease | Childhood Medulloblastoma | 2.06e-03 | 43 | 46 | 2 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.06e-03 | 43 | 46 | 2 | C1275668 | |
| Disease | Medullomyoblastoma | 2.06e-03 | 43 | 46 | 2 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.06e-03 | 43 | 46 | 2 | C0751291 | |
| Disease | Adult Medulloblastoma | 2.06e-03 | 43 | 46 | 2 | C0278876 | |
| Disease | serum alanine aminotransferase measurement | 2.20e-03 | 869 | 46 | 6 | EFO_0004735 | |
| Disease | coronary artery disease | 2.35e-03 | 1194 | 46 | 7 | EFO_0001645 | |
| Disease | C-reactive protein measurement | 2.48e-03 | 1206 | 46 | 7 | EFO_0004458 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.78e-03 | 50 | 46 | 2 | EFO_0022334 | |
| Disease | Medulloblastoma | 2.78e-03 | 50 | 46 | 2 | C0025149 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.89e-03 | 51 | 46 | 2 | EFO_0022331 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.89e-03 | 51 | 46 | 2 | EFO_0022285 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.89e-03 | 51 | 46 | 2 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTNQQMSPIIQSVGS | 1031 | Q99569 | |
| LETSQMSTTQAQAQP | 21 | O60885 | |
| TTVSQQIDMTTPSQI | 241 | Q8IZF6 | |
| NTSVTNVPNMSQMQT | 316 | Q92793 | |
| MKNSVQTPVENSTNS | 546 | Q9UHI6 | |
| TNSSIVVSPKMTRNQ | 251 | Q9NRD1 | |
| SVQQTQNMKASTSSP | 1701 | Q9C0F0 | |
| TNVRINSTMTTPQVL | 191 | P50749 | |
| SQVPRVMSTQRVANT | 471 | P11940 | |
| MSSTTTLTTPQNQVD | 136 | Q7LBR1 | |
| VISQRTQQTSSQMPA | 271 | O00592 | |
| PSTQTFMQTNERRQV | 3496 | Q8NEZ4 | |
| ENIANPMQTSSSVQQ | 351 | Q9BYH8 | |
| ETNSSRSTSEVNPQM | 91 | O95835 | |
| NPANTRSISNMTSQE | 431 | Q9UBS5 | |
| PQTFTQTSETAMVQV | 91 | Q6DN72 | |
| SIQPTSNMPNTSINR | 946 | Q5T0W9 | |
| TNPTITVVTSVTSNM | 366 | Q9NQ69 | |
| INQTETPIQTTFTMS | 361 | P11150 | |
| QNGSPMSQTETVSRS | 431 | Q9ULI3 | |
| SPSQSSMVARTQTVR | 371 | P51617 | |
| EQQPMQFQSQSTVSS | 1321 | O94916 | |
| TTTITTSSSRMQQPQ | 21 | Q8NDX5 | |
| QVPRVMSTQRVANTS | 466 | Q9H361 | |
| TTSRTLIMTTNNQTR | 641 | Q5XG87 | |
| TVNQGEMSSPQRVTS | 236 | P49023 | |
| EMSSPQRVTSTQQQT | 241 | P49023 | |
| PQQNSTYNVSVSTRM | 321 | P51003 | |
| RTSNVMITSNTTAPN | 951 | Q8IZL2 | |
| QQQSPVSQSMQTLSD | 571 | O43524 | |
| PMQVSFNTSDRSQTV | 881 | Q8NDG6 | |
| TIRSTVPQSQSQQTK | 236 | Q7Z3K3 | |
| TIRQTQVRSEPSNMQ | 171 | Q8NEZ3 | |
| TLNMQTSQLNTPQDT | 1941 | Q9UHV7 | |
| SPRQSMISTQNQYST | 306 | Q16513 | |
| AMLQTTTRPNQTPNS | 1071 | Q92954 | |
| VQIPSSMPQNSTQSA | 676 | O15516 | |
| QTQSSSRLSQVPMSA | 391 | Q7Z417 | |
| QVTNVSPSASSEQMR | 36 | Q05519 | |
| SNSMPSQSRSSVQRT | 626 | Q5PRF9 | |
| NQEKTPQSSTSSVQR | 16 | Q9UQR0 | |
| TFSVTMSNQQPQTIS | 651 | Q68DE3 | |
| SQEQLNTMTSTIPNS | 1296 | Q68DE3 | |
| NTMTSTIPNSQIQEP | 1301 | Q68DE3 | |
| STVPSILNRMQTNQT | 346 | Q93050 | |
| TSNLAQVNRTNMTPS | 181 | Q8N680 | |
| SRSQVTPQNQQMDSA | 341 | P15822 | |
| QESQERAMSTSQSPT | 181 | Q15776 | |
| TNLQNIPMVSSTQSS | 1801 | Q9NR99 |